FOLD
Featured PickAmicus Therapeutics, Inc.
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
72
Entry Price
$14.44
Current Price
$14.20
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-04-01
Executive Summary
Amicus Therapeutics (FOLD) is flashing a massive 8.0x relative volume surge at major resistance, driving an exceptional 15.0 confluence score. This extreme volume profile strongly implies an unreported fundamental development, potentially a bump in the pending $14.50 BioMarin acquisition offer. In the current CAUTION regime driven by geopolitical uncertainty, this SQUEEZE_PLAY setup offers a highly defensive yet explosive opportunity as capital rotates into stable, catalyst-driven names.
Technical Context
Setup
The stock is compressing tightly just 0.1% below its 52-week high, supported by a 1.3x 20-day average volume, a +0.8% 20-day return, and top quantitative signals including ALPHA_MALE and QUIET_STORM.
Invalidation (Stop)
The setup is invalidated if the price breaks and closes below the key $14.33 support level.
Runner-ups
DBRG— Solid 15.5 score and bullish data center acquisition news, but low 0.7x volume shows lack of immediate participation.
Recent Performance History
41 Total Picks • 56% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | TKO | $201.65 | $201.07 | -0.29% | N/A | N/A | N/A |
| 2026-03-30 | TKO | $195.41 | $201.07 | +2.90% | N/A | N/A | N/A |
| 2026-03-27 | PRA | $24.58 | $24.70 | +0.49% | N/A | N/A | N/A |
| 2026-03-26 | DAR | $58.98 | $62.16 | +5.39% | N/A | N/A | N/A |
| 2026-03-25 | ST | $36.40 | $35.18 | -3.35% | -3.35% | N/A | N/A |
| 2026-03-24 | DBRG | $15.40 | $15.45 | +0.32% | +0.13% | N/A | N/A |
| 2026-03-23 | DBRG | $15.38 | $15.45 | +0.46% | +0.13% | N/A | N/A |
| 2026-03-20 | CB | $322.58 | $327.16 | +1.42% | -1.08% | N/A | N/A |
| 2026-03-19 | AES | $14.15 | $14.20 | +0.35% | -0.99% | N/A | N/A |
| 2026-03-18 | KNX | $52.90 | $57.58 | +8.85% | +6.50% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0